742 related articles for article (PubMed ID: 25762732)
41. Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology.
Acosta EG; Kumar A; Bartenschlager R
Adv Virus Res; 2014; 88():1-109. PubMed ID: 24373310
[TBL] [Abstract][Full Text] [Related]
42. A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication.
Chatel-Chaix L; Fischl W; Scaturro P; Cortese M; Kallis S; Bartenschlager M; Fischer B; Bartenschlager R
J Virol; 2015 Jul; 89(14):7170-86. PubMed ID: 25926641
[TBL] [Abstract][Full Text] [Related]
43. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
44. Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses.
Villareal VA; Rodgers MA; Costello DA; Yang PL
Antiviral Res; 2015 Dec; 124():110-21. PubMed ID: 26526588
[TBL] [Abstract][Full Text] [Related]
45. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
47. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.
Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC
Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245
[TBL] [Abstract][Full Text] [Related]
48. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
[TBL] [Abstract][Full Text] [Related]
49. Important advances in the field of anti-dengue virus research.
Julander JG; Perry ST; Shresta S
Antivir Chem Chemother; 2011; 21(3):105-16. PubMed ID: 21233532
[TBL] [Abstract][Full Text] [Related]
50. Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.
Ferrari M; Zevini A; Palermo E; Muscolini M; Alexandridi M; Etna MP; Coccia EM; Fernandez-Sesma A; Coyne C; Zhang DD; Marques ETA; Olagnier D; Hiscott J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999020
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY
Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277
[TBL] [Abstract][Full Text] [Related]
52. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.
Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N
Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674
[TBL] [Abstract][Full Text] [Related]
53. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
54. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.
Tarasuk M; Songprakhon P; Chimma P; Sratongno P; Na-Bangchang K; Yenchitsomanus PT
Virus Res; 2017 Aug; 240():180-189. PubMed ID: 28864423
[TBL] [Abstract][Full Text] [Related]
55. [Introduction to the antivirals against Dengue virus].
Carocci M
Virologie (Montrouge); 2020 Aug; 24(4):231-245. PubMed ID: 32795980
[TBL] [Abstract][Full Text] [Related]
56. Molecular Mechanisms of Antiviral Agents against Dengue Virus.
Lee MF; Wu YS; Poh CL
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992414
[TBL] [Abstract][Full Text] [Related]
57. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in antiviral drug development towards dengue virus.
Troost B; Smit JM
Curr Opin Virol; 2020 Aug; 43():9-21. PubMed ID: 32795907
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of dengue virus replication by diisopropyl chrysin-7-yl phosphate.
Du J; Chen Z; Zhang T; Wang J; Jin Q
Sci China Life Sci; 2016 Aug; 59(8):832-8. PubMed ID: 27106619
[TBL] [Abstract][Full Text] [Related]
60. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
Kato F; Hishiki T
Viruses; 2016 May; 8(5):. PubMed ID: 27164125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
